215 related articles for article (PubMed ID: 9543090)
1. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit.
Bocan TM; Rosebury WS; Mueller SB; Kuchera S; Welch K; Daugherty A; Cornicelli JA
Atherosclerosis; 1998 Feb; 136(2):203-16. PubMed ID: 9543090
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation.
Bocan TM; Mueller SB; Mazur MJ; Uhlendorf PD; Brown EQ; Kieft KA
Atherosclerosis; 1993 Aug; 102(1):9-22. PubMed ID: 8257456
[TBL] [Abstract][Full Text] [Related]
3. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.
Bocan TM; Mueller SB; Uhlendorf PD; Newton RS; Krause BR
Arterioscler Thromb; 1991; 11(6):1830-43. PubMed ID: 1931885
[TBL] [Abstract][Full Text] [Related]
4. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
[TBL] [Abstract][Full Text] [Related]
5. Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits.
Bocan TM; Mueller SB; Brown EQ; Uhlendorf PD; Mazur MJ; Newton RS
Exp Mol Pathol; 1992 Aug; 57(1):70-83. PubMed ID: 1397193
[TBL] [Abstract][Full Text] [Related]
6. Dietary and mechanically induced rabbit iliac-femoral atherosclerotic lesions: a chemical and morphologic evaluation.
Bocan TM; Mueller SB; Uhlendorf PD; Ferguson E; Newton RS
Exp Mol Pathol; 1991 Jun; 54(3):201-77. PubMed ID: 2060606
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties.
Sendobry SM; Cornicelli JA; Welch K; Bocan T; Tait B; Trivedi BK; Colbry N; Dyer RD; Feinmark SJ; Daugherty A
Br J Pharmacol; 1997 Apr; 120(7):1199-206. PubMed ID: 9105693
[TBL] [Abstract][Full Text] [Related]
8. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation.
Bocan TM; Mazur MJ; Mueller SB; Brown EQ; Sliskovic DR; O'Brien PM; Creswell MW; Lee H; Uhlendorf PD; Roth BD
Atherosclerosis; 1994 Nov; 111(1):127-42. PubMed ID: 7840808
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
[TBL] [Abstract][Full Text] [Related]
10. The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression.
Bocan TM; Krause BR; Rosebury WS; Lu X; Dagle C; Bak Mueller S; Auerbach B; Sliskovic DR
Atherosclerosis; 2001 Jul; 157(1):97-105. PubMed ID: 11427208
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit.
Bocan TM; Mueller SB; Brown EQ; Lee P; Bocan MJ; Rea T; Pape ME
Atherosclerosis; 1998 Jul; 139(1):21-30. PubMed ID: 9699888
[TBL] [Abstract][Full Text] [Related]
12. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
Shen J; Herderick E; Cornhill JF; Zsigmond E; Kim HS; Kühn H; Guevara NV; Chan L
J Clin Invest; 1996 Nov; 98(10):2201-8. PubMed ID: 8941635
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase in monocytes emerges as a therapeutic target for intimal hyperplasia in a murine wire-injured femoral artery.
Baek SE; Jang MA; Lee SJ; Park SY; Bae SS; Kim CD
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2210-2219. PubMed ID: 28645655
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions.
Vijayagopal P; Srinivasan SR; Xu JH; Dalferes ER; Radhakrishnamurthy B; Berenson GS
J Clin Invest; 1993 Mar; 91(3):1011-8. PubMed ID: 8450030
[TBL] [Abstract][Full Text] [Related]
16. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
Namiki M; Kawashima S; Yamashita T; Ozaki M; Hirase T; Ishida T; Inoue N; Hirata K; Matsukawa A; Morishita R; Kaneda Y; Yokoyama M
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):115-20. PubMed ID: 11788470
[TBL] [Abstract][Full Text] [Related]
17. Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits.
Rival Y; Junquéro D; Bruniquel F; N'Guyen X; Fauré P; Pomiès JP; Degryse AD; Delhon A
J Cardiovasc Pharmacol; 2002 Feb; 39(2):181-91. PubMed ID: 11791003
[TBL] [Abstract][Full Text] [Related]
18. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study.
Ohtsuki K; Hayase M; Akashi K; Kopiwoda S; Strauss HW
Circulation; 2001 Jul; 104(2):203-8. PubMed ID: 11447087
[TBL] [Abstract][Full Text] [Related]
19. Chemical and physiochemical comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterol-fed New Zealand White and Watanabe Heritable Hyperlipidemic rabbits.
Nolte CJ; Tercyak AM; Wu HM; Small DM
Lab Invest; 1990 Feb; 62(2):213-22. PubMed ID: 2304334
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
Martínez-González J; Alfón J; Berrozpe M; Badimon L
Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
